Lactose (India) Ltd | 148 Cr. | 105 | 247/84.3 | 21.4 | 36.5 | 0.00 % | 18.0 % | 15.5 % | 10.0 |
MPS Pharmaa Ltd | 5.50 Cr. | 2.88 | 4.33/2.88 | | 0.80 | 0.00 % | 9.15 % | 34.9 % | 10.0 |
Gujarat Themis Biosyn Ltd | 2,663 Cr. | 244 | 390/192 | 50.6 | 20.5 | 0.27 % | 45.0 % | 33.8 % | 1.00 |
Gujarat Terce Laboratories Ltd | 44.7 Cr. | 60.2 | 94.9/44.5 | 15.1 | 11.9 | 0.00 % | 9.72 % | 3.44 % | 10.0 |
Gujarat Inject (Kerala) Ltd | 37.7 Cr. | 25.8 | 29.0/10.1 | 38.5 | 6.64 | 0.00 % | 2.65 % | 2.08 % | 10.0 |
Godavari Drugs Ltd | 69.1 Cr. | 91.8 | 155/79.0 | 11.2 | 55.4 | 0.00 % | 14.4 % | 15.5 % | 10.0 |
Glenmark Life Sciences Ltd | 13,316 Cr. | 1,084 | 1,335/666 | 31.4 | 207 | 2.07 % | 28.1 % | 21.1 % | 2.00 |
Gennex Laboratories Ltd | 295 Cr. | 13.0 | 29.0/11.4 | 15.9 | 7.93 | 0.00 % | 14.1 % | 10.2 % | 1.00 |
Ganga Pharmaceuticals Ltd | 4.92 Cr. | 10.2 | 27.1/9.25 | 98.4 | 14.6 | 0.00 % | 3.06 % | 0.80 % | 10.0 |
Fredun Pharmaceuticals Ltd | 305 Cr. | 645 | 1,024/635 | 16.2 | 277 | 0.11 % | 17.1 % | 14.3 % | 10.0 |
Fervent Synergies Ltd | 94.3 Cr. | 21.6 | 32.0/14.6 | | 8.11 | 0.00 % | 34.8 % | 34.9 % | 10.0 |
Fermenta Biotech Ltd | 772 Cr. | 262 | 449/145 | 21.9 | 98.6 | 0.48 % | 3.20 % | 5.59 % | 5.00 |
Fabino Enterprises Ltd | 5.21 Cr. | 24.8 | 36.5/22.8 | 104 | 20.0 | 0.00 % | 1.68 % | 1.21 % | 10.0 |
Evoq Remedies Ltd | 6.99 Cr. | 2.81 | 12.3/2.11 | | 17.2 | 0.00 % | 1.91 % | 1.80 % | 10.0 |
Everest Organics Ltd | 302 Cr. | 311 | 324/112 | | 50.6 | 0.00 % | 6.05 % | 0.30 % | 10.0 |
Entero Healthcare Solutions Ltd | 4,897 Cr. | 1,127 | 1,584/991 | 54.4 | 387 | 0.00 % | 6.71 % | 4.98 % | 10.0 |
Murae Organisor Ltd | 117 Cr. | 1.26 | 2.72/1.03 | 24.9 | 2.85 | 0.00 % | 0.79 % | 0.13 % | 2.00 |
Dipna Pharmachem Ltd | 37.9 Cr. | 15.8 | 16.6/6.40 | 45.7 | 15.8 | 0.00 % | 7.05 % | 3.52 % | 10.0 |
Decipher Labs Ltd | 11.8 Cr. | 11.7 | 24.6/10.1 | 51.5 | 21.3 | 0.00 % | 3.09 % | 6.75 % | 10.0 |
Coral Laboratories Ltd | 235 Cr. | 659 | 999/355 | 8.65 | 570 | 0.30 % | 12.6 % | 9.58 % | 10.0 |
Concord Drugs Ltd | 30.4 Cr. | 30.4 | 45.0/26.1 | | 33.9 | 0.00 % | 4.48 % | 1.28 % | 10.0 |
Colinz Laboratories Ltd | 23.1 Cr. | 50.6 | 88.7/36.0 | 47.2 | 20.5 | 0.00 % | 7.70 % | 5.73 % | 10.0 |
Cian Healthcare Ltd | 7.75 Cr. | 3.10 | 26.5/2.97 | | 15.8 | 0.00 % | 5.22 % | 0.43 % | 10.0 |
Chemo Pharma Laboratories Ltd | 18.3 Cr. | 122 | 154/55.1 | 45.8 | 91.1 | 0.00 % | 13.3 % | 9.67 % | 10.0 |
Checkpoint Trends Ltd | 9.80 Cr. | 17.9 | 19.4/6.08 | | 0.93 | 0.00 % | 3.36 % | 5.77 % | 10.0 |
Chandra Bhagat Pharma Ltd | 41.5 Cr. | 55.0 | 124/50.0 | 26.3 | 39.4 | 0.00 % | 7.95 % | 5.42 % | 10.0 |
Brawn Biotech Ltd | 5.01 Cr. | 16.7 | 27.8/15.5 | | 14.1 | 0.00 % | 25.9 % | 21.8 % | 10.0 |
Blue Jet Healthcare Ltd | 10,822 Cr. | 626 | 969/347 | 46.1 | 53.3 | 0.16 % | 30.0 % | 22.4 % | 2.00 |
Bharat Immunological & Biological Corporation Ltd | 96.7 Cr. | 22.4 | 35.9/19.0 | | 18.2 | 0.00 % | 9.27 % | 17.7 % | 10.0 |
Beryl Drugs Ltd | 11.5 Cr. | 22.6 | 46.0/20.3 | 144 | 18.3 | 0.00 % | 11.6 % | 8.95 % | 10.0 |
BDH Industries Ltd | 155 Cr. | 269 | 418/245 | 15.9 | 110 | 1.67 % | 20.6 % | 16.9 % | 10.0 |
Bacil Pharma Ltd | 25.7 Cr. | 43.7 | 62.6/14.8 | 73.5 | 2.87 | 0.00 % | 13.1 % | 13.8 % | 10.0 |
Aurobindo Pharma Ltd | 62,004 Cr. | 1,058 | 1,593/994 | 17.4 | 527 | 0.43 % | 14.1 % | 11.5 % | 1.00 |
Auro Laboratories Ltd | 153 Cr. | 246 | 307/156 | 44.1 | 69.6 | 0.00 % | 20.4 % | 20.5 % | 10.0 |
Anuh Pharma Ltd | 842 Cr. | 168 | 261/148 | 16.8 | 60.5 | 1.49 % | 25.6 % | 19.5 % | 5.00 |
ANG Lifesciences India Ltd | 38.5 Cr. | 29.5 | 62.8/21.0 | | 56.2 | 0.00 % | 1.78 % | 8.72 % | 10.0 |
Ami Organics Ltd | 8,732 Cr. | 2,133 | 2,644/1,008 | 71.8 | 294 | 0.14 % | 16.0 % | 9.37 % | 10.0 |
Amerise Biosciences Ltd | 5.88 Cr. | 0.89 | 1.45/0.55 | | 0.80 | 0.00 % | 2.73 % | 2.75 % | 1.00 |
Ambalal Sarabhai Enterprises Ltd | 281 Cr. | 36.7 | 77.7/34.1 | 19.8 | 18.3 | 0.00 % | 7.08 % | 4.22 % | 10.0 |
Adline Chem Lab Ltd | 5.71 Cr. | 9.76 | 27.3/9.76 | | 2.70 | 0.00 % | % | % | 10.0 |
Achyut Healthcare Ltd | 76.6 Cr. | 3.25 | 6.25/2.82 | 116 | 1.32 | 0.00 % | 3.27 % | 2.52 % | 1.00 |
Abbott India Ltd | 61,824 Cr. | 29,108 | 31,900/25,200 | 46.3 | 1,657 | 1.41 % | 46.0 % | 34.9 % | 10.0 |
Aarti Pharmalabs Ltd | 5,665 Cr. | 624 | 837/430 | 22.7 | 205 | 0.48 % | 16.6 % | 13.1 % | 5.00 |
Aarey Drugs & Pharmaceuticals Ltd | 137 Cr. | 48.0 | 75.8/31.3 | 24.0 | 47.8 | 0.00 % | 6.09 % | 3.74 % | 10.0 |
Zota Health Care Ltd | 2,148 Cr. | 773 | 1,078/440 | | 57.7 | 0.13 % | 7.32 % | 16.8 % | 10.0 |
Wockhardt Ltd | 19,495 Cr. | 1,200 | 1,680/489 | | 209 | 0.00 % | 0.83 % | 12.1 % | 5.00 |
Wanbury Ltd | 779 Cr. | 236 | 325/131 | 42.0 | 11.8 | 0.00 % | 60.6 % | % | 10.0 |
Vivimed Labs Ltd | 41.0 Cr. | 4.95 | / | | 3.12 | 0.00 % | 9.38 % | 233 % | 2.00 |
Venus Remedies Ltd | 399 Cr. | 298 | 428/270 | 14.3 | 370 | 0.00 % | 8.57 % | 5.94 % | 10.0 |
Unichem Laboratories Ltd | 3,921 Cr. | 556 | 950/433 | 46.3 | 341 | 0.00 % | 0.39 % | 1.17 % | 2.00 |
TTK Healthcare Ltd | 1,667 Cr. | 1,184 | 1,923/991 | 24.3 | 735 | 0.84 % | 8.67 % | 6.43 % | 10.0 |
Torrent Pharmaceuticals Ltd | 1,05,889 Cr. | 3,127 | 3,591/2,505 | 56.9 | 222 | 0.90 % | 23.2 % | 24.2 % | 5.00 |
Themis Medicare Ltd | 1,067 Cr. | 116 | 317/115 | 23.1 | 44.8 | 0.43 % | 13.5 % | 11.8 % | 1.00 |
Syncom Formulations (India) Ltd | 1,534 Cr. | 16.3 | 27.9/11.0 | 40.2 | 3.32 | 0.00 % | 10.2 % | 8.51 % | 1.00 |
Suven Pharmaceuticals Ltd | 26,963 Cr. | 1,059 | 1,360/597 | 96.6 | 77.7 | 0.00 % | 18.8 % | 14.1 % | 1.00 |
Suven Life Sciences Ltd | 2,604 Cr. | 119 | 169/83.0 | | 8.84 | 0.00 % | 36.4 % | 36.3 % | 1.00 |
Sun Pharmaceuticals Industries Ltd | 3,96,324 Cr. | 1,652 | 1,960/1,377 | 33.6 | 288 | 0.82 % | 17.3 % | 16.7 % | 1.00 |
Solara Active Pharma Sciences Ltd | 1,762 Cr. | 489 | 886/361 | | 301 | 0.00 % | 8.67 % | 33.5 % | 10.0 |
SMS Pharmaceuticals Ltd | 1,689 Cr. | 200 | 398/175 | 26.5 | 70.6 | 0.20 % | 11.2 % | 9.27 % | 1.00 |
SMS Lifesciences India Ltd | 333 Cr. | 1,095 | 1,750/626 | 15.8 | 621 | 0.14 % | 6.89 % | 3.66 % | 10.0 |
Shilpa Medicare Ltd | 5,957 Cr. | 610 | 960/418 | 70.4 | 238 | 0.00 % | 5.25 % | 1.71 % | 1.00 |
Sequent Scientific Ltd | 3,308 Cr. | 132 | 241/91.8 | 220 | 27.2 | 0.00 % | 0.44 % | 3.09 % | 2.00 |
Sanofi India Ltd | 13,934 Cr. | 6,039 | 7,600/4,146 | 38.4 | 374 | 1.94 % | 49.2 % | 38.6 % | 10.0 |
RPG Life Sciences Ltd | 3,256 Cr. | 1,970 | 2,977/1,381 | 34.1 | 229 | 0.81 % | 34.6 % | 25.5 % | 8.00 |
Procter & Gamble Health Ltd | 8,682 Cr. | 5,221 | 5,850/4,637 | 35.4 | 368 | 1.53 % | 45.0 % | 33.5 % | 10.0 |
Pharmaids Pharmaceuticals Ltd | 236 Cr. | 67.0 | 87.5/31.9 | | 19.0 | 0.00 % | 27.6 % | 16.8 % | 10.0 |
Pfizer Ltd | 18,465 Cr. | 4,035 | 6,453/3,701 | 30.0 | 820 | 0.87 % | 22.0 % | 16.1 % | 10.0 |
Par Drugs & Chemicals Ltd | 116 Cr. | 94.2 | 348/81.0 | 7.51 | 78.6 | 0.00 % | 25.0 % | 18.5 % | 10.0 |
Panacea Biotec Ltd | 2,709 Cr. | 442 | 491/112 | | 136 | 0.00 % | 3.57 % | 3.17 % | 1.00 |
Ortin Laboratories Ltd | 16.4 Cr. | 20.1 | 26.4/16.2 | | 3.47 | 0.00 % | 60.2 % | 118 % | 10.0 |
Orchid Pharma Ltd | 3,647 Cr. | 720 | 1,998/718 | 33.1 | 241 | 0.00 % | 9.37 % | 9.94 % | 10.0 |
Neuland Laboratories Ltd | 14,053 Cr. | 10,962 | 18,100/5,540 | 58.6 | 1,087 | 0.13 % | 33.3 % | 26.4 % | 10.0 |
Nectar Lifescience Ltd | 497 Cr. | 22.2 | 56.5/21.8 | 29.3 | 48.1 | 0.00 % | 5.97 % | 0.46 % | 1.00 |
Natco Pharma Ltd | 13,703 Cr. | 766 | 1,639/660 | 7.35 | 399 | 1.24 % | 30.1 % | 25.9 % | 2.00 |
Morepen Laboratories Ltd | 2,617 Cr. | 47.8 | 101/41.7 | 20.8 | 20.3 | 0.00 % | 16.8 % | 12.0 % | 2.00 |
Marksans Pharma Ltd | 8,824 Cr. | 195 | 359/130 | 24.0 | 50.3 | 0.31 % | 20.6 % | 16.5 % | 1.00 |
Mangalam Drugs and Organics Ltd | 116 Cr. | 73.3 | 145/70.1 | 11.3 | 93.2 | 0.00 % | 1.19 % | 6.12 % | 10.0 |
Lyka Labs Ltd | 360 Cr. | 101 | 177/90.2 | 87.9 | 27.7 | 0.00 % | 3.53 % | 5.07 % | 10.0 |
Lupin Ltd | 87,798 Cr. | 1,923 | 2,403/1,493 | 30.6 | 343 | 0.42 % | 15.7 % | 14.1 % | 2.00 |
Lincoln Pharmaceuticals Ltd | 1,078 Cr. | 536 | 980/498 | 12.1 | 319 | 0.34 % | 22.3 % | 16.8 % | 10.0 |
Laurus Labs Ltd | 30,266 Cr. | 561 | 646/385 | 121 | 79.2 | 0.14 % | 7.50 % | 5.43 % | 2.00 |
Kwality Pharmaceuticals Ltd | 817 Cr. | 787 | 1,070/441 | 23.2 | 234 | 0.00 % | 15.9 % | 13.7 % | 10.0 |
Krebs Biochemicals & Industries Ltd | 154 Cr. | 70.4 | 129/60.3 | | 60.4 | 0.00 % | 19.0 % | % | 10.0 |
Kopran Ltd | 843 Cr. | 175 | 370/155 | 17.8 | 103 | 1.72 % | 13.8 % | 11.0 % | 10.0 |
Kilitch Drugs (India) Ltd | 548 Cr. | 341 | 405/271 | 30.6 | 118 | 0.00 % | 12.6 % | 7.71 % | 10.0 |
Jubilant Pharmova Ltd | 14,079 Cr. | 883 | 1,310/608 | 42.3 | 373 | 0.57 % | 6.74 % | 0.76 % | 1.00 |
J B Chemicals & Pharmaceuticals Ltd | 23,629 Cr. | 1,518 | 2,030/1,303 | 36.9 | 207 | 0.81 % | 24.6 % | 20.0 % | 1.00 |
Jagsonpal Pharmaceuticals Ltd | 1,352 Cr. | 203 | 328/109 | 37.1 | 29.7 | 0.99 % | 17.0 % | 13.0 % | 2.00 |
Ipca Laboratories Ltd | 32,988 Cr. | 1,301 | 1,758/1,052 | 44.9 | 264 | 0.31 % | 12.8 % | 9.35 % | 1.00 |
IOL Chemicals & Pharmaceuticals Ltd | 1,752 Cr. | 59.8 | 108/57.5 | 18.0 | 56.5 | 1.67 % | 12.3 % | 8.68 % | 2.00 |
Ind-Swift Ltd | 68.9 Cr. | 13.0 | 34.7/12.5 | 1.07 | 122 | 0.00 % | 13.4 % | % | 2.00 |
Ind-Swift Laboratories Ltd | 491 Cr. | 83.1 | 186/74.0 | 5.94 | 171 | 0.00 % | 19.6 % | 17.4 % | 10.0 |
Indoco Remedies Ltd | 2,166 Cr. | 234 | 388/190 | | 118 | 0.64 % | 10.4 % | 8.33 % | 2.00 |
Hikal Ltd | 4,842 Cr. | 390 | 465/267 | 65.0 | 97.6 | 0.31 % | 7.79 % | 5.97 % | 2.00 |
Hester Biosciences Ltd | 1,403 Cr. | 1,657 | 3,379/1,243 | 45.4 | 355 | 0.36 % | 9.32 % | 6.60 % | 10.0 |
Gufic BioSciences Ltd | 3,097 Cr. | 310 | 504/278 | 37.8 | 57.3 | 0.03 % | 17.2 % | 20.0 % | 1.00 |
Granules India Ltd | 10,584 Cr. | 437 | 725/382 | 22.1 | 141 | 0.34 % | 15.4 % | 13.4 % | 1.00 |
Glenmark Pharmaceuticals Ltd | 40,716 Cr. | 1,442 | 1,831/985 | | 299 | 0.17 % | 12.3 % | 50.9 % | 1.00 |
Glaxosmithkline Pharmaceuticals Ltd | 43,666 Cr. | 2,574 | 3,088/1,825 | 51.1 | 98.7 | 1.24 % | 51.3 % | 37.3 % | 10.0 |
Gland Pharma Ltd | 23,321 Cr. | 1,416 | 2,221/1,200 | 20.8 | 557 | 1.41 % | 16.7 % | 12.3 % | 1.00 |
FDC Ltd | 6,447 Cr. | 397 | 659/359 | 23.5 | 141 | 1.26 % | 18.4 % | 14.2 % | 1.00 |
ERIS Lifesciences Ltd | 17,377 Cr. | 1,275 | 1,594/816 | 52.8 | 204 | 0.58 % | 11.3 % | 16.3 % | 1.00 |
Dr Reddys Laboratories Ltd | 90,797 Cr. | 1,088 | 1,421/1,020 | 16.9 | 369 | 0.74 % | 26.5 % | 21.4 % | 1.00 |
Dishman Carbogen Amcis Ltd | 2,997 Cr. | 191 | 308/133 | | 366 | 0.00 % | 0.02 % | 2.64 % | 2.00 |
Cipla Ltd | 1,11,807 Cr. | 1,385 | 1,702/1,310 | 22.4 | 351 | 0.94 % | 22.8 % | 16.8 % | 2.00 |
Caplin Point Laboratories Ltd | 14,015 Cr. | 1,845 | 2,641/1,221 | 27.2 | 334 | 0.27 % | 26.5 % | 24.2 % | 2.00 |
Brooks Laboratories Ltd | 297 Cr. | 113 | 203/72.5 | | 22.6 | 0.00 % | 24.7 % | 28.1 % | 10.0 |
Bliss GVS Pharma Ltd | 1,232 Cr. | 117 | 186/92.2 | 14.6 | 95.8 | 0.43 % | 14.4 % | 10.2 % | 1.00 |
Biofil Chemicals & Pharmaceuticals Ltd | 69.4 Cr. | 43.0 | 92.0/40.4 | 116 | 11.3 | 0.00 % | 4.94 % | 4.00 % | 10.0 |
Biocon Ltd | 36,902 Cr. | 308 | 405/260 | 44.8 | 175 | 0.16 % | 5.96 % | 5.25 % | 5.00 |
Beta Drugs Ltd | 1,798 Cr. | 1,782 | 2,215/1,048 | 43.9 | 179 | 0.00 % | 32.8 % | 26.0 % | 10.0 |
Bal Pharma Ltd | 176 Cr. | 110 | 158/76.3 | 24.3 | 43.2 | 1.09 % | 12.1 % | 11.0 % | 10.0 |
Bafna Pharmaceuticals Ltd | 170 Cr. | 72.0 | 113/67.8 | 36.5 | 35.0 | 0.00 % | 9.48 % | 9.44 % | 10.0 |
Astrazeneca Pharma India Ltd | 19,661 Cr. | 7,869 | 9,059/4,800 | 117 | 272 | 0.31 % | 31.1 % | 22.9 % | 2.00 |
Amrutanjan Health Care Ltd | 1,764 Cr. | 612 | 863/548 | 35.8 | 103 | 0.75 % | 21.3 % | 15.5 % | 1.00 |
Alpa Laboratories Ltd | 217 Cr. | 103 | 145/69.9 | 8.64 | 83.0 | 0.00 % | 13.7 % | 11.2 % | 10.0 |
Alkem Laboratories Ltd | 56,258 Cr. | 4,700 | 6,440/4,407 | 26.0 | 961 | 0.85 % | 19.7 % | 19.6 % | 2.00 |
Alembic Pharmaceuticals Ltd | 16,598 Cr. | 845 | 1,304/725 | 28.0 | 249 | 1.30 % | 13.1 % | 13.3 % | 2.00 |
Albert David Ltd | 448 Cr. | 782 | 1,754/763 | 11.1 | 724 | 1.47 % | 27.8 % | 21.7 % | 10.0 |
Ajanta Pharma Ltd | 29,594 Cr. | 2,374 | 3,486/2,022 | 33.0 | 294 | 1.52 % | 31.6 % | 23.2 % | 2.00 |
Advanced Enzyme Technologies Ltd | 3,021 Cr. | 270 | 571/258 | 21.2 | 120 | 1.89 % | 15.2 % | 11.2 % | 2.00 |
Aarti Drugs Limited | 2,958 Cr. | 322 | 635/312 | 22.4 | 126 | 0.31 % | 13.7 % | 12.4 % | 10.0 |
Industry Average | 16,817.48 Cr | 1,037.90 | | 40.26 | 182.59 | 0.37% | 16.01% | 16.31% | 6.24 |